关注我们


个人简介
2005.09--2010.07 南昌大学医学院(江西医学院)临床医学专业本科学习
2010.09--2015.06 中山大学外科学专业博士研究生(硕博连读)
2015.07—2020.12 广东省人民医院乳腺科医师
2021.01—2024.12 广东省人民医院乳腺科主治医师
2025.01—至今 广东省人民医院乳腺科副主任医师 硕士生导师
研究方向
乳腺癌的手术治疗,系统治疗以及毒副作用的管理
代表性论著
1. Yang CQ*, Li W, Li SQ, et al. MCP-1 stimulates MMP-9 expression via ERK 1/2 and p38 MAPK signaling pathways in human aortic smooth muscle cells. Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 2014;34:266-76. (IF=5.5, 共同第一作者第一位)
2. Shi Y, Yang CQ*, Wang SW, Li W, Li J, Wang SM. Characterization of Fc gamma receptor IIb expression within abdominal aortic aneurysm. Biochemical and biophysical research communications 2017;485:295-300. (IF=3.575, 共同第一作者第二位)
3. Li Yuwen, Yang Ciqiu*, Shi Yi, et al. A Pilot Study of Protein Microarray for Simultaneous Analysis of 274 Cytokines Between Abdominal Aortic Aneurysm and Normal Aorta. Angiology. 2019;70(9):830-837. (IF=3.619, 共同第一作者第二位)
4. Yang CQ*, Ji Fie, Gao HongFei, et al. The Role of Sharp Dissection in Nipple-Sparing Mastectomy: A Safe Procedure with No Necrosis of the Nipple-Areolar Complex. Cancer management and research. 2019;11:10223-10228. (IF=3.989, 共同第一作者第一位)
5. Ji Fei, Xiao Weikai, Yang Ciqiu*, et al. Tumor location of the central and nipple portion is associated with impaired survival for women with breast cancer. Cancer management and research. 2019;11:2915-2925. (IF=3.989, 共同第一作者第三位)
6. Yang C*, Lei C, Zhang Y, et al. Comparison of Overall Survival Between Invasive Lobular Breast Carcinoma and Invasive Ductal Breast Carcinoma: A Propensity Score Matching Study Based on SEER Database. Frontiers in oncology 2020;10:590643. (IF=6.244, 共同第一作者第一位)
7. Lei Chuqian, Yang Ciqiu*, Xia Bin, et al. Analysis of Tau Protein Expression in Predicting Pathological Complete Response to Neoadjuvant Chemotherapy in Different Molecular Subtypes of Breast Cancer. Journal of breast cancer. 2020;23(1):47-58. (IF=3.588, 共同第一作者第二位)
8. Ji Fei, Yang Ciqiu*, Li Xiaolin, et al. Risk of breast cancer-related death in women with a prior cancer. Aging. 2020;12(7):5894-5906. (IF=5.682, 共同第一作者第二位)
9. Gao Xinya, Lai Yuanhui,Yang Ciqiu*, et al. Long Non-coding RNA RP11-480I12.5 Promotes the Proliferation, Migration, and Invasion of Breast Cancer Cells Through the miR-490-3p-AURKA-Wnt/β-Catenin Axis. Frontiers in oncology. 2020;10:948. (IF=6.244, 共同通讯作者倒数第二位)
10. Junsheng Zhang*, Ciqiu Yang*, Yi Zhang*, Fei Ji, Hongfei Gao, Xiaosheng Zhuang, Weiping Li, Weijun Pan, Bo Shen, Tingfeng Zhang, Yuanqi Chen, Kun Wang. Effects of Surgery on Prognosis of Young Women With Operable Breast Cancer in Different Marital Statuses: A Population-Based Cohort Study. Front Oncol. 2021 Jun 23;11:666316. (IF=6.244, 共同第一作者第二位)
11. Zhang J*, Yang C*, Lei C, Zhang Y, Ji F, Gao H, Yang M, Zhang L, Li J, Zhu T, Li W, Zhuang X, Wang K. Survival outcomes after breast-conserving therapy compared with mastectomy for patients with early-stage metaplastic breast cancer: a population-based study of 2412 patients. Breast. 2021 Apr 1;58:10-17. (IF=4.254,共同第一作者第二位)
12. Zeng Fang*, Ruizhi Wang*, Ciqiu Yang* et al. A Novel Predictive Nomogram including Serum Lipoprotein a Level for Nonsentinel Lymph Node Metastases in Chinese Breast Cancer Patients with Positive Sentinel Lymph Node Metastases. Disease Markers. 2021 Nov 22; (IF=3.464, 共同第一作者第三位)
13. Ciqiu Yang * Junsheng Zhang * et al. Low-dose Apatinib Combined with Neoadjuvant Chemotherapy in the Treatment of Early-stage Triple Negative Breast Cancer (LANCET): A Single-center, Single-arm, Phase II Trial. Ther Adv Med Oncol 2022. (IF=5.485, 共同第一作者第一位)
14. Junsheng Zhang *, Hong-Fei Gao*, Ciqiu Yang * et al. Prevention of taxane-associated acute pain syndrome with etoricoxib for patients with breast cancer: A phase II randomised trial. Eur J Cancer. 2022 Jun 16;171:150-160 (IF=10.002, 共同第一作者第三位)
15. Ciqiu Yang*,Xiaoqi Zhang et al. Survival differences between HER2-0 and HER2-low-expressing breast cancer - A meta-analysis of early breast cancer patients. Crit Rev Oncol Hematol. 2023 May;185:103962(IF=6.8,共同第一作者第一位)
16. Peiyong Li*, Ciqiu Yang *,Junsheng Zhang*, et al, Survival After Sentinel Lymph Node Biopsy Compared with Axillary Lymph Node Dissection for Female Patients with T3-4c Breast Cancer, Oncologist; 2023 Mar 17(IF=5.8,共同第一作者第二位)
17. Ciqiu Yang*,Peiyong Li et al. Pooled analysis of NeoCARH and NeoCART trials: patient‐reported outcomes in patients with early‐stage breast cancer receiving platinum‐based or anthracycline‐based neoadjuvant chemotherapy. Supportive Care in Cancer (2024) 32:401(IF=2.8,共同第一作者第一位)
18. Xiaoqi Zhang, Ciqiu Yang et al. Application of preoperative three-dimensional vascular reconstruction assessment in preventing ischemic complications after nipple-sparing mastectomy: a randomized controlled trial.International Journal of Surgery.2025 Nov 13.(IF=10.1,共同第一作者第二位)
代表性课题
1. MCP-1对MDA-MB-231,MDA-MB-468和HCC70细胞上皮间质转化的调控在三阴性乳腺癌侵袭转移发病机制的研究 (广东省医学科学技术研究基金项目合同书:A2019252, 结题,主持)
2. 外泌体LncRNA RP11-480I12.5促进AURKA通路调节三阴性乳腺癌的侵袭与转移(2023年度基础与应用基础研究专题,2023A04J0516,主持,结题)
学术任职
1. 中国临床肿瘤学会(CSCO)青年委员会委员
2. 中国临床肿瘤学会乳腺癌专业委员会委员
3. 中华医学会肿瘤分会乳腺肿瘤青年学组委员
4. 广东省预防医学会乳腺癌防治专业委员会常务委员兼秘书
荣誉奖励
1. 2021年国家肿瘤质控中心乳腺癌MDT大赛全国总冠军(国家癌症中心举办)
2. 2021年“叁星辉映”全国乳腺癌MDT大赛全国总冠军(中华医学会,中国临床肿瘤学会,中国抗癌协会联合举办)
3. 2022年获中国临床肿瘤学会主办全国“35under35”优秀青年肿瘤医生(乳腺肿瘤组第一)